McDonald's Shares Down Amid Drugs
This is a news story, published by CBS News, that relates primarily to McDonald news.
drug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsCBS News news
For more news from CBS News, you can click here:
more news from CBS NewsAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
McDonald. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest other fast food brands news, food businesses news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
fast food chainCBS News
•Health
Health
McDonald's shares slip after downgrade spurred by weight-loss drug popularity

78% Informative
Analysts downgraded McDonald 's stock rating two notches, from buy to sell.
GLP-1s are designed to help regulate users' blood sugar and appetite.
The appetite-suppressing drugs are expected to have a transformative effect on how Americans consume food.
McDonald's could lose up to 28 million customer visits, resulting in a revenue loss of $482 million per year.
VR Score
88
Informative language
94
Neutral language
65
Article tone
semi-formal
Language
English
Language complexity
55
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links